These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

753 related items for PubMed ID: 31796570

  • 1. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O, Magliano DJ, Salim A, Koye DN, Shaw JE.
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [Abstract] [Full Text] [Related]

  • 2. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [Abstract] [Full Text] [Related]

  • 3. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G, Solini A, Bonora E, Orsi E, Fondelli C, Zerbini G, Trevisan R, Vedovato M, Cavalot F, Laviola L, Nicolucci A, Pugliese G, Renal Insufficiency and Cardiovascular Events (RIACE) Study Group.
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [Abstract] [Full Text] [Related]

  • 4. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M, Russo E, Miccoli R, Lucchesi D, Giusti L, Sancho-Bornez V, Daniele G, Del Prato S, Penno G.
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [Abstract] [Full Text] [Related]

  • 5. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q, Luk AO, Lau ESH, Tam CHT, Ozaki R, Lim CKP, Wu H, Jiang G, Chow EYK, Ng JK, Kong APS, Fan B, Lee KF, Siu SC, Hui G, Tsang CC, Lau KP, Leung JY, Tsang MW, Kam G, Lau IT, Li JK, Yeung VT, Lau E, Lo S, Fung S, Cheng YL, Chow CC, Huang Y, Lan HY, Szeto CC, So WY, Chan JCN, Ma RCW, Hong Kong Diabetes Biobank Study Group.
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [Abstract] [Full Text] [Related]

  • 6. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H, Araki SI, Kawai K, Yamazaki K, Shirabe SI, Sugimoto H, Minami M, Miyazawa I, Maegawa H, JDDM Study Group.
    Diabetes Care; 2020 May; 43(5):1102-1110. PubMed ID: 32144168
    [Abstract] [Full Text] [Related]

  • 7. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
    Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Scardapane M, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
    Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
    [Abstract] [Full Text] [Related]

  • 8. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, Japan Diabetes Clinical Data Management Study Group.
    Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ, San Andrés-Rebollo FJ, de Burgos-Lunar C, Abánades-Herranz JC, Carrillo-de-Santa-Pau E, Chico-Moraleja RM, Jiménez-García R, López-de-Andrés A, Gómez-Campelo P, MADIABETES Group.
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [Abstract] [Full Text] [Related]

  • 10. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Penno G, Russo E, Garofolo M, Daniele G, Lucchesi D, Giusti L, Sancho Bornez V, Bianchi C, Dardano A, Miccoli R, Del Prato S.
    Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
    [Abstract] [Full Text] [Related]

  • 13. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes.
    Viazzi F, Piscitelli P, Giorda C, Ceriello A, Genovese S, Russo GT, Fioretto P, Guida P, De Cosmo S, Pontremoli R, AMD-Annals Study Group.
    J Diabetes Complications; 2017 Feb; 31(2):419-426. PubMed ID: 27884661
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease.
    Ito H, Antoku S, Izutsu T, Kusano E, Matsumoto S, Yamasaki T, Mori T, Togane M.
    Clin Exp Nephrol; 2020 Nov; 24(11):1033-1043. PubMed ID: 32734506
    [Abstract] [Full Text] [Related]

  • 16. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

  • 17. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.
    Perkovic V, Toto R, Cooper ME, Mann JFE, Rosenstock J, McGuire DK, Kahn SE, Marx N, Alexander JH, Zinman B, Pfarr E, Schnaidt S, Meinicke T, von Eynatten M, George JT, Johansen OE, Wanner C, CARMELINA investigators.
    Diabetes Care; 2020 Aug; 43(8):1803-1812. PubMed ID: 32444457
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes.
    Lee HW, Jo AR, Yi DW, Kang YH, Son SM.
    Endocrinol Metab (Seoul); 2016 Dec; 31(4):577-585. PubMed ID: 28029027
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
    Penno G, Solini A, Orsi E, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Zerbini G, Lamacchia O, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
    BMC Med; 2021 Mar 15; 19(1):66. PubMed ID: 33715620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.